Westerville, OH, United States of America

Brian K Kaspar

USPTO Granted Patents = 29 (Patent Applications = 36)

CIPO Patents = 6 (Patent Applications = 14)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 271(Granted Patents)

Location History:

San Diego, CA (US) (2006 - 2019)
New Albany, OH (US) (2017 - 2019)
Columbus, OH (US) (2010 - 2020)
Westerville, OH (US) (2014 - 2024)

Company Filing History:

11 out of 63

Nationwide Children's Hospital, Inc.

patents

10 out of 1,507

The Ohio State University

patents

9 out of 106

Research Institute at Nationwide Children's Hospital

patents

4. 4 out of 15,528

University of California

patents

5. 3 out of 577

The Salk Institute for Biological Studies

Integrative Gene Therapeutics

patent

8. 1 out of 525

Ludwig Institute for Cancer Research Limited

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404523 - Adeno-associated virus delivery of CLN3 polynucleotide (2025-09-02),

2. 12357663 - Intrathecal delivery of recombinant adeno-associated virus encoding methyl-CpG binding protein 2 (2025-07-15),

3. 12228571 - Cell-based assay for measuring drug product potency (2025-02-18),

4. 12208144 - Intrathecal delivery of recombinant adeno-associated virus 9 (2025-01-28),

5. 12168777 - Means and method for producing and purifying viral vectors (2024-12-17),

6. 12077748 - Methods and materials for producing recombinant viruses in eukaryotic microalgae (2024-09-03),

7. 11738094 - Intrathecal delivery of recombinant adeno-associated virus 9 (2023-08-29),

8. 11730829 - Intrathecal delivery of recombinant adeno-associated virus 9 (2023-08-22),

9. 11583564 - Intrathecal delivery of recombinant adeno-associated virus encoding Methyl-CpG binding protein 2 (2023-02-21),

10. 11413357 - Intrathecal delivery of recombinant adeno-associated virus 9 (2022-08-16),

11. 11311634 - Intrathecal delivery of recombinant Adeno-associated virus 9 (2022-04-26),

12. 11219696 - Delivery of polynucleotides using recombinant AAV9 (2022-01-11),

13. 11040116 - Intrathecal delivery of recombinant adeno-associated virus 9 (2021-06-22),

14. 10907130 - Methods and materials for producing recombinant viruses in eukaryotic microalgae (2021-02-02),

15. 10842886 - Guided injections for AAV gene transfer to muscle (2020-11-24),

Title: The Innovative Journey of Brian K Kaspar

Introduction:

Brian K Kaspar, a talented inventor hailing from Westerville, Ohio, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Brian K Kaspar's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

With over two decades of experience in research and development, Brian K Kaspar has a proven track record of turning innovative ideas into practical solutions. His work has been instrumental in shaping the future of various industries.

Collaborations:

Throughout his career, Brian K Kaspar has collaborated with leading research institutions, top universities, and renowned companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been key to his success.

Conclusion:

In conclusion, Brian K Kaspar's passion for innovation, coupled with his dedication to pushing the boundaries of technology, has established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.